![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, November 04, 2010 12:18:05 PM
On November 3, 2010, CardioGenics Holdings Inc. (the “Company”) sold 3,861,150 shares of its common stock (the “ Private Placement Shares ”) to 13 investors (the “Investor(s)”) in exchange for $1,930,575, or $0.50 per share, pursuant to subscription agreements entered into between the Company and each Investor (the “ Subscription Agreements ”). The Private Placement Shares do not have any registration rights and are subject to the rights and restrictions of Rule 144. Further, no warrants were issued in connection with the private placement. All of the securities issuances referenced above were exempt from registration under Section 4 (2) of the Securities Act of 1933, as issuances not involving a public offering.
Recent CGNH News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/26/2024 04:25:43 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM